Education
About Us
Working with TipRanks
Follow Us
Actinogen Medical Limited (ATGGF)
OTHER OTC:ATGGF
ATGGF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.03
Previous CloseN/A
Volume684.50K
Average Volume (3M)10.03K
Market Cap
$53.74M
Enterprise Value$53.68M
Total Cash (Recent Filing)$22.87M
Total Debt (Recent Filing)AU$289.64K
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,177,147,200
10 Day Avg. Volume30,000
30 Day Avg. Volume10,033
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)3.04
Price to Sales (P/S)0.00
P/FCF Ratio-9.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Actinogen Medical News
PremiumCompany Announcements
Actinogen Medical Advances Alzheimer’s Trial with Key Milestone
PremiumCompany Announcements
BVF Partners Ceases Substantial Holding in Actinogen Medical
PremiumCompany Announcements
Actinogen’s Xanamem Shows Promise in Depression Treatment
PremiumCompany Announcements
Actinogen Medical Advances Alzheimer’s Treatment with Xanamem
PremiumCompany Announcements
Actinogen Medical Prepares for Xanamem Commercialization with Upcoming Forum
PremiumCompany Announcements
Actinogen Medical Sees Change in Substantial Holder’s Voting PowerOptions Prices
Currently, No data available
---
Ownership Overview
ATGGF FAQ
What was Actinogen Medical Limited’s price range in the past 12 months?
Actinogen Medical Limited lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is Actinogen Medical Limited’s market cap?
Actinogen Medical Limited’s market cap is $53.74M.
When is Actinogen Medical Limited’s upcoming earnings report date?
Actinogen Medical Limited’s upcoming earnings report date is Aug 27, 2025 which is in 36 days.
How were Actinogen Medical Limited’s earnings last quarter?
Currently, no data Available
Is Actinogen Medical Limited overvalued?
According to Wall Street analysts Actinogen Medical Limited’s price is currently Overvalued.
Does Actinogen Medical Limited pay dividends?
Actinogen Medical Limited does not currently pay dividends.
What is Actinogen Medical Limited’s EPS estimate?
Actinogen Medical Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Actinogen Medical Limited have?
Actinogen Medical Limited has 3,177,147,200 shares outstanding.
What happened to Actinogen Medical Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Actinogen Medical Limited?
Currently, no hedge funds are holding shares in ATGGF
Actinogen Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
ATGGF Sentiment 88%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.85%
12-Months-Change
Fundamentals
Return on Equity
-55.44%
Trailing 12-Months
Asset Growth
62.90%
Trailing 12-Months
Company Description
Actinogen Medical Limited
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Technical Analysis
Alterity Therapeutics
―
Prescient Therapeutics Limited
―
Radiopharm Theranostics Limited
―
EZZ Life Science Holdings Ltd.
―
Arovella Therapeutics Limited
―